{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:00:45Z","timestamp":1791234045344,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-24-00222"],"award-info":[{"award-number":["24-24-00222"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03130-4","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T03:57:53Z","timestamp":1763438273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Temozolomide-induced senescent glioblastoma cells acquire sensitivity to TRAIL death receptor 5-mediated apoptosis"],"prefix":"10.1007","volume":"43","author":[{"given":"Alina A.","family":"Isakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana V.","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezhda V.","family":"Antipova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina N.","family":"Druzhkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0410rtem \u041c.","family":"Mozherov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill S.","family":"Krasnov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman S.","family":"Fadeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail P.","family":"Kirpichnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine E.","family":"Gasparian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne V.","family":"Yagolovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"3130_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1134\/S000629792301008X","volume":"88","author":"MA Zamkova","year":"2023","unstructured":"Zamkova MA, Persiyantseva NA, Tatarskiy VV, Shtil AA. Therapy-induced tumor cell senescence: mechanisms and circumvention. Biochem Mosc. 2023;88:86\u2013104. https:\/\/doi.org\/10.1134\/S000629792301008X.","journal-title":"Biochem Mosc"},{"key":"3130_CR2","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s43018-022-00462-2","volume":"3","author":"L Wang","year":"2022","unstructured":"Wang L, Jin H, Jochems F, Wang S, Lieftink C, Martinez IM, et al. cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis. Nat Cancer. 2022;3:1284\u201399. https:\/\/doi.org\/10.1038\/s43018-022-00462-2.","journal-title":"Nat Cancer"},{"key":"3130_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2021.10.038","volume":"525","author":"A Soto-Gamez","year":"2022","unstructured":"Soto-Gamez A, Wang Y, Zhou X, Seras L, Quax W, Demaria M. Enhanced extrinsic apoptosis of therapy-induced senescent cancer cells using a death receptor 5 (DR5) selective agonist. Cancer Lett. 2022;525:67\u201375. https:\/\/doi.org\/10.1016\/j.canlet.2021.10.038.","journal-title":"Cancer Lett"},{"key":"3130_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1042\/BST20220098","volume":"51","author":"F Di Cristofano","year":"2023","unstructured":"Di Cristofano F, George A, Tajiknia V, Ghandali M, Wu L, Zhang Y, et al. Therapeutic targeting of TRAIL death receptors. Biochem Soc Trans. 2023;51:57\u201370. https:\/\/doi.org\/10.1042\/BST20220098.","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"3130_CR5","doi-asserted-by":"publisher","first-page":"RCR5154","DOI":"10.59761\/RCR5154","volume":"94","author":"AV Yagolovich","year":"2025","unstructured":"Yagolovich AV, Gasparian ME, Isakova AA, Artykov AA, Dolgikh DA, Kirpichnikov MP. Cytokine TRAIL death receptor agonists: design strategies and clinical prospects. Russ Chem Rev. 2025;94:RCR5154. https:\/\/doi.org\/10.59761\/RCR5154.","journal-title":"Russ Chem Rev"},{"key":"3130_CR6","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1186\/s12885-023-11489-8","volume":"23","author":"Z Xia","year":"2023","unstructured":"Xia Z, Leng Y, Fang B, Liang Y, Li W, Fu C, Yang L, Ke X, Jiang H, Weng J, Liu L, Zhao Y, Zhang X, Huang Z, Liu A, Shi Q, Gao Y, Chen X, Pan L, Cai Z, Wang Z, Wang Y, Fan Y, Hou M, Ma Y, Hu J, Liu J, Zhou J, Zhang X, Meng H, Lu X, Li F, Ren H, Huang B, Shao Z, Zhou H, Hu Y, Yang S, Zheng X, Wei P, Pang H, Yu W, Liu Y, Gao S, Yan L, Ma Y, Jing H, Du J, Ling W, Zhang J, Sui W, Wang F, Li X, Chen W. Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial. BMC Cancer. 2023;23:980. https:\/\/doi.org\/10.1186\/s12885-023-11489-8.","journal-title":"BMC Cancer"},{"key":"3130_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s40265-024-02004-9","volume":"84","author":"S Dhillon","year":"2024","unstructured":"Dhillon S. Aponermin: first approval. Drugs. 2024;84:459\u201366. https:\/\/doi.org\/10.1007\/s40265-024-02004-9.","journal-title":"Drugs"},{"key":"3130_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11060-005-9081-1","volume":"78","author":"JM Kuijlen","year":"2006","unstructured":"Kuijlen JM, Mooij JJA, Platteel I, Hoving EW, Van Der Graaf WT, Span MM, et al. TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme. J Neurooncol. 2006;78:161\u201371. https:\/\/doi.org\/10.1007\/s11060-005-9081-1.","journal-title":"J. Neurooncol."},{"key":"3130_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30558-3","volume":"13","author":"D Bhere","year":"2022","unstructured":"Bhere D, Choi SH, Van De Donk P, Hope D, Gortzak K, Kunnummal A, et al. Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells. Nat Commun. 2022;13:2810. https:\/\/doi.org\/10.1038\/s41467-022-30558-3.","journal-title":"Nat Commun"},{"key":"3130_CR10","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/j.1582-4934.2009.00777.x","volume":"14","author":"AC Bellail","year":"2010","unstructured":"Bellail AC, Tse MCL, Song JH, Phuphanich S, Olson JJ, Sun SY, Hao C. DR5-mediated DISC controls caspase\u20108 cleavage and initiation of apoptosis in human glioblastomas. J Cell Mol Med. 2010;14:1303\u201317. https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00777.x.","journal-title":"J Cell Mol Med"},{"key":"3130_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s10555-018-9728-y","volume":"37","author":"X Yuan","year":"2018","unstructured":"Yuan X, Gajan A, Chu Q, Xiong H, Wu K, Wu GS. Developing TRAIL\/TRAIL death receptor-based cancer therapies. Cancer Metastasis Rev. 2018;37:733\u201348. https:\/\/doi.org\/10.1007\/s10555-018-9728-y.","journal-title":"Cancer Metastasis Rev"},{"key":"3130_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100762","volume":"13","author":"AV Yagolovich","year":"2020","unstructured":"Yagolovich AV, Artykov AA, Karmakova TA, Vorontsova MS, Pankratov AA, Andreev-Andrievsky AA, et al. Genetically modified DR5-specific TRAIL variant DR5-B revealed dual antitumor and protumoral effect in colon cancer xenografts and an improved pharmacokinetic profile. Transl Oncol. 2020;13:100762. https:\/\/doi.org\/10.1016\/j.tranon.2020.100762.","journal-title":"Transl Oncol"},{"key":"3130_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/sj.bjc.6600711","volume":"88","author":"W G\u00fcnther","year":"2003","unstructured":"G\u00fcnther W, Pawlak E, Damasceno R, Arnold H, Terzis AJ. Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids. Br J Cancer. 2003;88:463\u20139. https:\/\/doi.org\/10.1038\/sj.bjc.6600711.","journal-title":"Br J Cancer"},{"key":"3130_CR14","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3390\/cancers14092233","volume":"14","author":"L Beltzig","year":"2022","unstructured":"Beltzig L, Schwarzenbach C, Leukel P, Frauenknecht KBM, Sommer C, Tancredi A, et al. Senescence is the main trait induced by temozolomide in glioblastoma cells. Cancers. 2022;14:2233. https:\/\/doi.org\/10.3390\/cancers14092233.","journal-title":"Cancers"},{"key":"3130_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41467-023-36124-9","volume":"14","author":"R Salam","year":"2023","unstructured":"Salam R, Saliou A, Bielle F, Bertrand M, Antoniewski C, Carpentier C, Alentorn A, Capelle L, Sanson M, Huillard E, Bellenger L, Gu\u00e9gan J, Le Roux I. Cellular senescence in malignant cells promotes tumor progression in mouse and patient glioblastoma. Nat Commun. 2023;14:441. https:\/\/doi.org\/10.1038\/s41467-023-36124-9.","journal-title":"Nat Commun"},{"key":"3130_CR16","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.3390\/cells11162588","volume":"11","author":"L Beltzig","year":"2022","unstructured":"Beltzig L, Christmann M, Kaina B. Abrogation of cellular senescence induced by temozolomide in glioblastoma cells: search for senolytics. Cells. 2022;11:2588. https:\/\/doi.org\/10.3390\/cells11162588.","journal-title":"Cells"},{"key":"3130_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00476-8","volume":"7","author":"C Riviere-Cazaux","year":"2023","unstructured":"Riviere-Cazaux C, Carlstrom LP, Neth BJ, Olson IE, Rajani K, Rahman M, et al. An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence. NPJ Precis Oncol. 2023;7:126. https:\/\/doi.org\/10.1038\/s41698-023-00476-8.","journal-title":"NPJ Precis Oncol"},{"key":"3130_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1134\/S0006297919060051","volume":"84","author":"AV Yagolovich","year":"2019","unstructured":"Yagolovich AV, Artykov AA, Dolgikh DA, Kirpichnikov MP, Gasparian ME. A new efficient method for production of recombinant antitumor cytokine TRAIL and its receptor-selective variant DR5-B. Biochem Mosc. 2019;84:627\u201336. https:\/\/doi.org\/10.1134\/S0006297919060051.","journal-title":"Biochem Mosc"},{"key":"3130_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0891-5849(02)00959-0","volume":"33","author":"A Brunk","year":"2002","unstructured":"Brunk A, Terman A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function12 1Guest editor: Rajindar S. Sohal 2This article is part of a series of reviews on \u201cOxidative Stress and Aging.\u201d the full list of papers may be found on the homepage of the journal. Free Radic Biol Med. 2002;33:611\u20139. https:\/\/doi.org\/10.1016\/S0891-5849(02)00959-0.","journal-title":"Free Radic Biol Med"},{"key":"3130_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/APO.0000000000000292","volume":"9","author":"J Orellana-Rios","year":"2020","unstructured":"Orellana-Rios J, Yokoyama S, Bhuiyan A, Gao L, Otero-Marquez O, Smith RT. Translational retinal imaging. Asia Pac J Ophthalmol. 2020;9:269\u201377. https:\/\/doi.org\/10.1097\/APO.0000000000000292.","journal-title":"Asia Pac J Ophthalmol"},{"key":"3130_CR21","doi-asserted-by":"publisher","unstructured":"Gray DA, Woulfe J. Lipofuscin and aging: A matter of toxic waste. Sci Aging Knowl Environ. 2005;2005. https:\/\/doi.org\/10.1126\/sageke.2005.5.re1.","DOI":"10.1126\/sageke.2005.5.re1"},{"key":"3130_CR22","doi-asserted-by":"publisher","first-page":"e90746","DOI":"10.1371\/journal.pone.0090746","volume":"9","author":"AT Shah","year":"2014","unstructured":"Shah AT, Demory Beckler M, Walsh AJ, Jones WP, Pohlmann PR, Skala MC. Optical metabolic imaging of treatment response in human head and neck squamous cell carcinoma. PLoS One. 2014;9:e90746. https:\/\/doi.org\/10.1371\/journal.pone.0090746.","journal-title":"PLoS One"},{"key":"3130_CR23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"3130_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol. 1995;57:289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"3130_CR25","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3130_CR26","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, Thorvaldsd\u00f3ttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27:1739\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btr260.","journal-title":"Bioinformatics"},{"key":"3130_CR27","doi-asserted-by":"publisher","first-page":"btac757","DOI":"10.1093\/bioinformatics\/btac757","volume":"39","author":"Z Fang","year":"2023","unstructured":"Fang Z, Liu X, Peltz G. Gseapy: a comprehensive package for performing gene set enrichment analysis in python. Bioinformatics. 2023;39:btac757. https:\/\/doi.org\/10.1093\/bioinformatics\/btac757.","journal-title":"Bioinformatics"},{"key":"3130_CR28","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504. https:\/\/doi.org\/10.1101\/gr.1239303.","journal-title":"Genome Res"},{"key":"3130_CR29","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607\u201313. https:\/\/doi.org\/10.1093\/nar\/gky1131.","journal-title":"Nucleic Acids Res"},{"key":"3130_CR30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/bioinformatics\/btt019","volume":"29","author":"G Bindea","year":"2013","unstructured":"Bindea G, Galon J, Mlecnik B. Cluepedia Cytoscape plugin: pathway insights using integrated experimental and in silico data. Bioinformatics. 2013;29:661\u20133. https:\/\/doi.org\/10.1093\/bioinformatics\/btt019.","journal-title":"Bioinformatics"},{"key":"3130_CR31","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"C-H Chin","year":"2014","unstructured":"Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y. Cytohubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8:S11. https:\/\/doi.org\/10.1186\/1752-0509-8-S4-S11.","journal-title":"BMC Syst Biol"},{"key":"3130_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.12688\/f1000research.4524.1","volume":"3","author":"K Nishida","year":"2014","unstructured":"Nishida K, Ono K, Kanaya S, Takahashi K. Keggscape: a cytoscape app for pathway data integration. F1000Res. 2014;3:144. https:\/\/doi.org\/10.12688\/f1000research.4524.1.","journal-title":"F1000Res"},{"key":"3130_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1158\/0008-5472.CAN-18-1733","volume":"79","author":"D Aasland","year":"2019","unstructured":"Aasland D, G\u00f6tzinger L, Hauck L, Berte N, Meyer J, Effenberger M, Schneider S, Reuber EE, Roos WP, Tomicic MT, Kaina B, Christmann M. Temozolomide induces senescence and repression of DNA repair pathways in glioblastoma cells via activation of ATR\u2013CHK1, p21, and NF-\u03baB. Cancer Res. 2019;79:99\u2013113. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-1733.","journal-title":"Cancer Res"},{"issue":"3","key":"3130_CR34","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1750-3639.1999.tb00536.x","volume":"9","author":"N Ishii","year":"1999","unstructured":"Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, Diserens A, et al. Frequent co-alterations of TP53, p16\/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol. 1999;9(3):469\u201379. https:\/\/doi.org\/10.1111\/j.1750-3639.1999.tb00536.x.","journal-title":"Brain Pathol"},{"key":"3130_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01568","volume":"9","author":"H Abe","year":"2020","unstructured":"Abe H, Natsumeda M, Okada M, Watanabe J, Tsukamoto Y, Kanemaru Y, et al. MGMT expression contributes to temozolomide resistance in H3K27M-mutant diffuse midline gliomas. Front Oncol. 2020;9:1568. https:\/\/doi.org\/10.3389\/fonc.2019.01568.","journal-title":"Front Oncol"},{"key":"3130_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.18632\/aging.100527","volume":"5","author":"E Georgakopoulou","year":"2012","unstructured":"Georgakopoulou E, Tsimaratou K, Evangelou K, Fernandez M-P, Zoumpourlis V, Trougakos I, et al. Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues. Aging. 2012;5:37\u201350. https:\/\/doi.org\/10.18632\/aging.100527.","journal-title":"Aging"},{"key":"3130_CR37","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s10495-009-0349-3","volume":"14","author":"ME Gasparian","year":"2009","unstructured":"Gasparian ME, Chernyak BV, Dolgikh DA, Yagolovich AV, Popova EN, Sycheva AM, Moshkovskii SA, Kirpichnikov MP. Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5. Apoptosis. 2009;14:778\u201387. https:\/\/doi.org\/10.1007\/s10495-009-0349-3.","journal-title":"Apoptosis"},{"key":"3130_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25:25\u20139. https:\/\/doi.org\/10.1038\/75556.","journal-title":"Nat Genet"},{"key":"3130_CR39","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14839","author":"AM Scaffa","year":"2021","unstructured":"Scaffa AM, Peterson AL, Carr JF, Garcia D, Yao H, Dennery PA. Hyperoxia causes senescence and increases glycolysis in cultured lung epithelial cells. Physiol Rep. 2021. https:\/\/doi.org\/10.14814\/phy2.14839.","journal-title":"Physiol Rep"},{"key":"3130_CR40","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/s42255-023-00912-w","volume":"5","author":"X Dou","year":"2023","unstructured":"Dou X, Fu Q, Long Q, Liu S, Zou Y, Fu D, Xu Q, Jiang Z, Ren X, Zhang G, Wei X, Li Q, Campisi J, Zhao Y, Sun Y. PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy. Nat Metab. 2023;5:1887\u2013910. https:\/\/doi.org\/10.1038\/s42255-023-00912-w.","journal-title":"Nat Metab"},{"key":"3130_CR41","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.7150\/thno.84912","volume":"13","author":"YJ Park","year":"2023","unstructured":"Park YJ, Kim JC, Kim Y, Kim YH, Park SS, Muther C, Tessier A, Lee G, Gendronneau G, Forestier S, Ben-Khalifa Y, Park TJ, Kang HY. Senescent melanocytes driven by glycolytic changes are characterized by melanosome transport dysfunction. Theranostics. 2023;13:3914\u201324. https:\/\/doi.org\/10.7150\/thno.84912.","journal-title":"Theranostics"},{"key":"3130_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/jb\/mvae032","volume":"176","author":"S Kawakami","year":"2024","unstructured":"Kawakami S, Johmura Y, Nakanishi M. Intracellular acidification and glycolysis modulate inflammatory pathway in senescent cells. J Biochem. 2024;176:97\u2013108. https:\/\/doi.org\/10.1093\/jb\/mvae032.","journal-title":"J Biochem"},{"key":"3130_CR43","doi-asserted-by":"publisher","first-page":"8766","DOI":"10.1158\/0008-5472.CAN-04-3922","volume":"65","author":"DK Bird","year":"2005","unstructured":"Bird DK, Yan L, Vrotsos KM, Eliceiri KW, Vaughan EM, Keely PJ, White JG, Ramanujam N. Metabolic mapping of MCF10A human breast cells via multiphoton fluorescence lifetime imaging of the coenzyme NADH. Cancer Res. 2005;65:8766\u201373. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3922.","journal-title":"Cancer Res"},{"key":"3130_CR44","doi-asserted-by":"publisher","first-page":"8911","DOI":"10.1038\/s41598-017-09426-4","volume":"7","author":"MV Shirmanova","year":"2017","unstructured":"Shirmanova MV, Druzhkova IN, Lukina MM, Dudenkova VV, Ignatova NI, Snopova LB, Shcheslavskiy VI, Belousov VV, Zagaynova EV. Chemotherapy with cisplatin: insights into intracellular pH and metabolic landscape of cancer cells in vitro and in vivo. Sci Rep. 2017;7:8911. https:\/\/doi.org\/10.1038\/s41598-017-09426-4.","journal-title":"Sci Rep"},{"key":"3130_CR45","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/ph16060796","volume":"16","author":"DV Yuzhakova","year":"2023","unstructured":"Yuzhakova DV, Sachkova DA, Shirmanova MV, Mozherov AM, Izosimova AV, Zolotova AS, et al. Measurement of patient-derived glioblastoma cell response to Temozolomide using fluorescence lifetime imaging of NAD(P)H. Pharmaceuticals. 2023;16:796. https:\/\/doi.org\/10.3390\/ph16060796.","journal-title":"Pharmaceuticals"},{"key":"3130_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.969812","volume":"12","author":"M Morelli","year":"2022","unstructured":"Morelli M, Lessi F, Barachini S, Liotti R, Montemurro N, Perrini P, et al. Metabolic-imaging of human glioblastoma live tumors: a new precision-medicine approach to predict tumor treatment response early. Front Oncol. 2022;12:969812. https:\/\/doi.org\/10.3389\/fonc.2022.969812.","journal-title":"Front. Oncol."},{"key":"3130_CR47","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s42003-024-06123-7","volume":"7","author":"A Song","year":"2024","unstructured":"Song A, Zhao N, Hilpert DC, Perry C, Baur JA, Wallace DC, Schaefer PM. Visualizing subcellular changes in the NAD(H) pool size versus redox state using fluorescence lifetime imaging microscopy of NADH. Commun Biol. 2024;7:428. https:\/\/doi.org\/10.1038\/s42003-024-06123-7.","journal-title":"Commun Biol"},{"key":"3130_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074466","volume":"8","author":"C Quintavalle","year":"2013","unstructured":"Quintavalle C, Mangani D, Roscigno G, Romano G, Diaz-Lagares A, Iaboni M, et al. miR-221\/222 target the DNA methyltransferase MGMT in glioma cells. PLoS One. 2013;8:e74466. https:\/\/doi.org\/10.1371\/journal.pone.0074466.","journal-title":"PLoS One"},{"key":"3130_CR49","doi-asserted-by":"publisher","unstructured":"Martin S, Janouskova H, Dontenwill M. Integrins and p53 pathways in glioblastoma resistance to Temozolomide. Front Oncol. 2012;2. https:\/\/doi.org\/10.3389\/fonc.2012.00157.","DOI":"10.3389\/fonc.2012.00157"},{"key":"3130_CR50","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3892\/or.2016.4917","volume":"36","author":"X Su","year":"2016","unstructured":"Su X, Liu X, Ni L, Shi W, Zhu H, Shi J, Chen J, Gu Z, Gao Y, Lan Q, Huang Q. GFAP expression is regulated by Pax3 in brain glioma stem cells. Oncol Rep. 2016;36:1277\u201384. https:\/\/doi.org\/10.3892\/or.2016.4917.","journal-title":"Oncol Rep"},{"key":"3130_CR51","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1134\/S0006297924100079","volume":"89","author":"AA Isakova","year":"2024","unstructured":"Isakova AA, Druzhkova IN, Mozherov AM, Mazur DV, Antipova NV, Krasnov KS, Fadeev RS, Gasparian ME, Yagolovich AV. Glioblastoma sensitization to therapeutic effects by glutamine deprivation depends on cellular phenotype and metabolism. Biochem Mosc. 2024;89:1744\u201358. https:\/\/doi.org\/10.1134\/S0006297924100079.","journal-title":"Biochem Mosc"},{"key":"3130_CR52","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.bbrc.2013.03.021","volume":"433","author":"X Jin","year":"2013","unstructured":"Jin X, Jin X, Jung J-E, Beck S, Kim H. Cell surface Nestin is a biomarker for glioma stem cells. Biochem Biophys Res Commun. 2013;433:496\u2013501. https:\/\/doi.org\/10.1016\/j.bbrc.2013.03.021.","journal-title":"Biochem Biophys Res Commun"},{"key":"3130_CR53","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13046-015-0163-4","volume":"34","author":"B Wu","year":"2015","unstructured":"Wu B, Sun C, Feng F, Ge M, Xia L. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis. J Exp Clin Cancer Res. 2015;34:44. https:\/\/doi.org\/10.1186\/s13046-015-0163-4.","journal-title":"J Exp Clin Cancer Res"},{"key":"3130_CR54","doi-asserted-by":"publisher","first-page":"5360","DOI":"10.1158\/0008-5472.CAN-17-1294","volume":"77","author":"K-H Chow","year":"2017","unstructured":"Chow K-H, Park HJ, George J, Yamamoto K, Gallup AD, Graber JH, Chen Y, Jiang W, Steindler DA, Neilson EG, Kim BYS, Yun K. S100A4 is a biomarker and regulator of glioma stem cells that is critical for mesenchymal transition in glioblastoma. Cancer Res. 2017;77:5360\u201373. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1294.","journal-title":"Cancer Res"},{"key":"3130_CR55","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jcma.2016.03.010","volume":"79","author":"W-S Song","year":"2016","unstructured":"Song W-S, Yang Y-P, Huang C-S, Lu K-H, Liu W-H, Wu W-W, Lee Y-Y, Lo W-L, Lee S-D, Chen Y-W, Huang P-I, Chen M-T. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. J Chin Med Assoc. 2016;79:538\u201345. https:\/\/doi.org\/10.1016\/j.jcma.2016.03.010.","journal-title":"J Chin Med Assoc"},{"key":"3130_CR56","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.molmed.2012.05.004","volume":"18","author":"LWS Finley","year":"2012","unstructured":"Finley LWS, Haigis MC. Metabolic regulation by SIRT3: implications for tumorigenesis. Trends Mol Med. 2012;18:516\u201323. https:\/\/doi.org\/10.1016\/j.molmed.2012.05.004.","journal-title":"Trends Mol Med"},{"issue":"15","key":"3130_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306027","volume":"11","author":"V Vella","year":"2024","unstructured":"Vella V, Ditsiou A, Chalari A, Eravci M, Wooller SK, Gagliano T, et al. Kinome-wide synthetic lethal screen identifies PANK4 as a modulator of temozolomide resistance in glioblastoma. Adv Sci. 2024;2306027. https:\/\/doi.org\/10.1002\/advs.202306027.","journal-title":"Adv Sci"},{"key":"3130_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdad047","volume":"5","author":"M Thang","year":"2023","unstructured":"Thang M, Mellows C, Mercer-Smith A, Nguyen P, Hingtgen S. Current approaches in enhancing TRAIL therapies in glioblastoma. Neuro-Oncol Adv. 2023;5:vdad047. https:\/\/doi.org\/10.1093\/noajnl\/vdad047.","journal-title":"Neuro-Oncol Adv"},{"key":"3130_CR59","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/acel.12632","volume":"16","author":"CD Wiley","year":"2017","unstructured":"Wiley CD, Flynn JM, Morrissey C, Lebofsky R, Shuga J, Dong X, Unger MA, Vijg J, Melov S, Campisi J. Analysis of individual cells identifies cell-to\u2010cell variability following induction of cellular senescence. Aging Cell. 2017;16:1043\u201350. https:\/\/doi.org\/10.1111\/acel.12632.","journal-title":"Aging Cell"},{"key":"3130_CR60","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/onc.2012.206","volume":"32","author":"A Sagiv","year":"2013","unstructured":"Sagiv A, Biran A, Yon M, Simon J, Lowe SW, Krizhanovsky V. Granule exocytosis mediates immune surveillance of senescent cells. Oncogene. 2013;32:1971\u20137. https:\/\/doi.org\/10.1038\/onc.2012.206.","journal-title":"Oncogene"},{"key":"3130_CR61","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10522-013-9473-0","volume":"14","author":"A Sagiv","year":"2013","unstructured":"Sagiv A, Krizhanovsky V. Immunosurveillance of senescent cells: the bright side of the senescence program. Biogerontology. 2013;14:617\u201328. https:\/\/doi.org\/10.1007\/s10522-013-9473-0.","journal-title":"Biogerontology"},{"key":"3130_CR62","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/ng.3590","volume":"48","author":"J Wang","year":"2016","unstructured":"Wang J, Cazzato E, Ladewig E, Frattini V, Rosenbloom DIS, Zairis S, Abate F, Liu Z, Elliott O, Shin Y-J, Lee J-K, Lee I-H, Park W-Y, Eoli M, Blumberg AJ, Lasorella A, Nam D-H, Finocchiaro G, Iavarone A, Rabadan R. Clonal evolution of glioblastoma under therapy. Nat Genet. 2016;48:768\u201376. https:\/\/doi.org\/10.1038\/ng.3590.","journal-title":"Nat Genet"},{"key":"3130_CR63","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature12437","volume":"501","author":"JR D\u00f6rr","year":"2013","unstructured":"D\u00f6rr JR, Yu Y, Milanovic M, Beuster G, Zasada C, D\u00e4britz JHM, Lisec J, Lenze D, Gerhardt A, Schleicher K, Kratzat S, Purf\u00fcrst B, Walenta S, Mueller-Klieser W, Gr\u00e4ler M, Hummel M, Keller U, Buck AK, D\u00f6rken B, Willmitzer L, Reimann M, Kempa S, Lee S, Schmitt CA. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature. 2013;501:421\u20135. https:\/\/doi.org\/10.1038\/nature12437.","journal-title":"Nature"},{"key":"3130_CR64","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","volume":"22","author":"R Di Micco","year":"2021","unstructured":"Di Micco R, Krizhanovsky V, Baker D, d\u2019Adda F, Fagagna D. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat Rev Mol Cell Biol. 2021;22:75\u201395. https:\/\/doi.org\/10.1038\/s41580-020-00314-w.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3130_CR65","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature25167","volume":"553","author":"M Milanovic","year":"2018","unstructured":"Milanovic M, Fan DNY, Belenki D, D\u00e4britz JHM, Zhao Z, Yu Y, D\u00f6rr JR, Dimitrova L, Lenze D, Monteiro Barbosa IA, Mendoza-Parra MA, Kanashova T, Metzner M, Pardon K, Reimann M, Trumpp A, D\u00f6rken B, Zuber J, Gronemeyer H, Hummel M, Dittmar G, Lee S, Schmitt CA. Senescence-associated reprogramming promotes cancer stemness. Nature. 2018;553:96\u2013100. https:\/\/doi.org\/10.1038\/nature25167.","journal-title":"Nature"},{"key":"3130_CR66","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/febs.13968","volume":"284","author":"D Siegmund","year":"2017","unstructured":"Siegmund D, Lang I, Wajant H. Cell death-independent activities of the death receptors <sc>CD<\/sc> 95, <sc>TRAILR<\/sc> 1, and <sc>TRAILR<\/sc> 2. FEBS J. 2017;284:1131\u201359. https:\/\/doi.org\/10.1111\/febs.13968.","journal-title":"FEBS J"},{"key":"3130_CR67","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486\u2013541. https:\/\/doi.org\/10.1038\/s41418-017-0012-4.","journal-title":"Cell Death Differ"},{"key":"3130_CR68","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1134\/S1990747822060101","volume":"17","author":"YV Lomovskaya","year":"2023","unstructured":"Lomovskaya YV, Kobyakova MI, Senotov AS, Fadeeva IS, Lomovsky AI, Krasnov KS, et al. Myeloid differentiation increases resistance of leukemic cells to TRAIL-induced death by reducing the expression of DR4 and DR5 receptors. Biochem Mosc Suppl Ser Membr Cell Biol. 2023;17:43\u201357. https:\/\/doi.org\/10.1134\/S1990747822060101.","journal-title":"Biochem Mosc Suppl Ser Membr Cell Biol"},{"key":"3130_CR69","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1158\/0008-5472.CAN-18-2558","volume":"79","author":"H-K Park","year":"2019","unstructured":"Park H-K, Hong J-H, Oh YT, Kim SS, Yin J, Lee A-J, Chae YC, Kim JH, Park S-H, Park C-K, Park M-J, Park JB, Kang BH. Interplay between TRAP1 and Sirtuin-3 modulates mitochondrial respiration and oxidative stress to maintain stemness of glioma stem cells. Cancer Res. 2019;79:1369\u201382. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2558.","journal-title":"Cancer Res"},{"key":"3130_CR70","doi-asserted-by":"publisher","first-page":"e114388","DOI":"10.1371\/journal.pone.0114388","volume":"9","author":"W Abdel Khalek","year":"2014","unstructured":"Abdel Khalek W, Cortade F, Ollendorff V, Lapasset L, Tintignac L, Chabi B, et al. SIRT3, a mitochondrial NAD+-dependent deacetylase, is involved in the regulation of myoblast differentiation. PLoS ONE. 2014;9:e114388. https:\/\/doi.org\/10.1371\/journal.pone.0114388.","journal-title":"PLoS ONE"},{"key":"3130_CR71","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-05093-z","volume":"81","author":"W Wei","year":"2024","unstructured":"Wei W, Li T, Chen J, Fan Z, Gao F, Yu Z, et al. SIRT3\/6: an amazing challenge and opportunity in the fight against fibrosis and aging. Cell Mol Life Sci. 2024;81:69. https:\/\/doi.org\/10.1007\/s00018-023-05093-z.","journal-title":"Cell Mol Life Sci"},{"key":"3130_CR72","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1002\/jcp.25669","volume":"232","author":"J Chen","year":"2017","unstructured":"Chen J, Wang A, Chen Q. SirT3 and p53 deacetylation in aging and cancer. J Cell Physiol. 2017;232:2308\u201311. https:\/\/doi.org\/10.1002\/jcp.25669.","journal-title":"J Cell Physiol"},{"key":"3130_CR73","doi-asserted-by":"publisher","first-page":"8315","DOI":"10.7150\/thno.45922","volume":"10","author":"J Zhang","year":"2020","unstructured":"Zhang J, Xiang H, Liu J, Chen Y, He R-R, Liu B. Mitochondrial sirtuin 3: new emerging biological function and therapeutic target. Theranostics. 2020;10:8315\u201342. https:\/\/doi.org\/10.7150\/thno.45922.","journal-title":"Theranostics"},{"key":"3130_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217106","volume":"598","author":"R Yang","year":"2024","unstructured":"Yang R, Kwan W, Du Y, Yan R, Zang L, Li C, et al. Drug-induced senescence by aurora kinase inhibitors attenuates innate immune response of macrophages on gastric cancer organoids. Cancer Lett. 2024;598:217106. https:\/\/doi.org\/10.1016\/j.canlet.2024.217106.","journal-title":"Cancer Lett"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03130-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03130-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03130-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T03:49:43Z","timestamp":1769485783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03130-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3130"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03130-4","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study with glioblastoma patient-derived cells was performed according to the Declaration of Helsinki, and approved by the Ethics Committee of the N.N. Burdenko National Medical Research Center of Neurosurgery (protocol #176 from 29 August 2019). The samples were de-identified before being processed to the research laboratory. All the patients have provided written informed consent for participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"4"}}